Perform Another (Advanced) Search

1.  Study Posting (5015) Trial #128954, Pregnancy, Various cites, WY
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

2.  Study Posting (5015) Trial #128952, Pregnancy, Various cites, WI
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

3.  Study Posting (5015) Trial #128950, Pregnancy, Various cites, WV
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

4.  Study Posting (5015) Trial #128948, Pregnancy, Various cites, WA
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

5.  Study Posting (5015) Trial #128946, Pregnancy, Various cites, VA
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

6.  Study Posting (5015) Trial #128944, Pregnancy, Various cites, VT
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

7.  Study Posting (5015) Trial #128942, Pregnancy, Various cites, UT
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

8.  Study Posting (5015) Trial #128940, Pregnancy, Various cites, TX
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

9.  Study Posting (5015) Trial #128938, Pregnancy, Various cites, TN
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

10.  Study Posting (5015) Trial #128936, Pregnancy, Various cites, SD
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

11.  Study Posting (5015) Trial #128934, Pregnancy, Various cites, SC
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

12.  Study Posting (5015) Trial #128932, Pregnancy, Various cites, RI
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

13.  Study Posting (5015) Trial #128930, Pregnancy, Various cites, PA
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

14.  Study Posting (5015) Trial #128928, Pregnancy, Various cites, OR
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

15.  Study Posting (5015) Trial #128926, Pregnancy, Various cites, OK
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

16.  Study Posting (5015) Trial #128924, Pregnancy, Various cites, OH
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

17.  Study Posting (5015) Trial #128922, Pregnancy, Various cites, ND
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

18.  Study Posting (5015) Trial #128920, Pregnancy, Various cites, NC
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

19.  Study Posting (5015) Trial #128918, Pregnancy, Various cites, NY
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page

20.  Study Posting (5015) Trial #128916, Pregnancy, Various cites, NM
...Registry are to evaluate the percentage of other adverse pregnancy outcomes (e.g., spontaneous abortion, stillbirth, preterm birth) and any potential impact of exenatide (BYETTA) use during breastfeeding among pregnancies or ...
View Page